Mcgill University

Hydroxychloroquine maintenance, compared with reducing or discontinuing, is associated with a lower risk for flare among patients with systemic lupus erythematosus in remission or very low disease activity, according to data presented here.

Depressive symptoms and clinically significant depression were frequent more than 12 weeks after SARS-CoV-2 infection, according to a systematic review published in Journal of Psychiatric Research.

There is no doubt that patients with rheumatic and autoimmune diseases are taking full advantage of relaxed laws in the United States surrounding recreational cannabis use.

A retracted New England Journal of Medicine study on the link between CVD, renin-angiotensin–aldosterone system inhibitor therapy and COVID-19 outcomes continues to be “widely cited” in medical literature, researchers wrote.

The addition of nivolumab to neoadjuvant chemotherapy appeared safe and did not impact timing or feasibility of surgery among patients with resectable non-small cell lung cancer, according to results of the phase 3 CheckMate 816 trial.

A polygenic risk score can predict adult short stature among children with accuracy similar to the use of midparental height, according to data published in The Journal of Clinical Endocrinology & Metabolism.

Parents reported that two-thirds of children with juvenile idiopathic arthritis demonstrate drug side effects that impact their quality of life within 1 year of diagnosis, according to data published in Arthritis Care & Research.

An animated video that was shown to children with a history of food-related anaphylaxis improved their understanding of anaphylaxis and how manage it, data show.

Baseline prednisone use is associated with an increased risk for poor outcomes among patients with systemic lupus erythematosus who are tapering hydroxychloroquine, according to data published in Arthritis Care & Research.

American Association for Cancer Research announced the 2020-2021 class of FDA-AACR oncology educational fellows.